Page 9 - Nasdaq Podd News Today

Insulet Co. (NASDAQ:PODD – Get Rating)’s stock price was down 3% during mid-day trading on Tuesday . The stock traded as low as $287.78 and last traded at $287.83. Approximately 140,424 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 701,642 shares. The stock had previously closed at […]

Insulet Co. (NASDAQ:PODD – Get Rating) SVP Dan Manea sold 175 shares of the firm’s stock in a transaction dated Tuesday, June 20th. The shares were sold at an average price of $290.00, for a total transaction of $50,750.00. Following the completion of the transaction, the senior vice president now directly owns 4,522 shares in […]

Insulet Co. (NASDAQ:PODD – Get Rating) SVP Dan Manea sold 175 shares of Insulet stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $290.00, for a total transaction of $50,750.00. Following the completion of the sale, the senior vice president now directly owns 4,522 shares of the […]

Insulet (NASDAQ:PODD – Get Rating) and Femasys (NASDAQ:FEMY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of current recommendations for Insulet and […]

Fred Alger Management LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 10.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 565,632 shares of the medical instruments supplier’s stock after selling 66,419 shares during the quarter. Insulet comprises about 0.9% […]

Natixis grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 606.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 71,354 shares of the medical instruments supplier’s stock after acquiring an additional 61,257 shares during the period. Natixis’ holdings in Insulet were worth $20,935,000 at the end of the most recent reporting […]

Insulet Co. (NASDAQ:PODD – Get Rating) Director Luciana Borio sold 500 shares of Insulet stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $283.38, for a total value of $141,690.00. Following the transaction, the director now owns 2,350 shares of the company’s stock, valued at approximately $665,943. […]

Dimensional Fund Advisors LP increased its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 2.4% in the fourth quarter, HoldingsChannel reports. The firm owned 116,447 shares of the medical instruments supplier’s stock after purchasing an additional 2,782 shares during the period. Dimensional Fund Advisors LP’s holdings in Insulet were worth $34,280,000 at […]

Fund Management at Engine No. 1 LLC bought a new position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) during the fourth quarter, Holdings Channel.com reports. The fund bought 765 shares of the medical instruments supplier’s stock, valued at approximately $225,000. Other large investors have also recently made changes to their positions in the […]

Insulet Co. (NASDAQ:PODD – Get Rating) – Research analysts at William Blair issued their Q1 2024 earnings estimates for Insulet in a note issued to investors on Thursday, May 25th. William Blair analyst M. Kaczor forecasts that the medical instruments supplier will post earnings of $0.32 per share for the quarter. The consensus estimate for […]